• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Novo Nordisk A/S

    Recent news which mentions Novo Nordisk A/S

    < Previous 1 2 3 4 5 6 7 8 Next >
    How the Research Triangle has helped make North Carolina one of America's fastest-growing economies
    Tags Technology Consumer Staples Consumer Finance
    From CNBC.com News
    CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain
    Tickers JOBS
    Tags Market Outlook Interest Rates Technology
    From CNBC.com News
    Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
    Tags Novo Nordisk A/S US: News Business
    From CNBC.com News
    Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
    Tags Health care industry Novo Nordisk A/S Biotech and Pharmaceuticals
    From CNBC.com News
    Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
    Tags Social issues Eli Lilly and Co Abbott Laboratories
    From CNBC.com News
    5 things to know before the stock market opens Tuesday
    Tags Investing Business Economy
    From CNBC.com News
    Weight loss drugs cut Covid-19 deaths, study finds
    Tags Europe Markets Europe News Business
    From CNBC.com News
    Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
    Tags Pharmaceuticals Biotechnology Business
    From CNBC.com News
    Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
    Tags Breaking News: Technology Biotechnology Business
    From CNBC.com News
    Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
    Tags Eli Lilly and Co Health & Science Companies
    From CNBC.com News
    What's next for the Biden administration's Medicare drug price negotiations
    Tags Pharmaceuticals Bristol/Myers Squibb Co Novo Nordisk A/S
    From CNBC.com News
    Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
    Tags Novo Nordisk A/S Abbvie Inc Biotechnology
    From CNBC.com News
    Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
    Tags Health & Science Healthy Returns Eli Lilly and Co
    From CNBC.com News
    Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
    Tags Health care industry Biotech and Pharmaceuticals Business News
    From CNBC.com News
    Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
    Tags Novo Nordisk A/S US: News Business
    From CNBC.com News
    Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
    Tags Novo Nordisk A/S US: News Business
    From CNBC.com News
    Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
    Tags Viking Therapeutics Inc Health care industry Biotech and Pharmaceuticals
    From CNBC.com News
    Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
    Tags Breaking News: Business Science Companies
    From CNBC.com News
    Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
    Tags Biotechnology Business Roche Holding AG
    From CNBC.com News
    Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
    Tags Eli Lilly and Co Breaking News: Business Companies
    From CNBC.com News
    Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
    Tags Pharmaceuticals Biotechnology Biotech and Pharmaceuticals
    From CNBC.com News
    Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
    Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
    From CNBC.com News
    Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
    Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health & Science
    From CNBC.com News
    Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
    Tags Eli Lilly and Co Zealand Pharma A/S Markets
    From CNBC.com News
    Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
    Tags Biotech and Pharmaceuticals Novo Nordisk A/S UnitedHealth Group Inc
    From CNBC.com News
    Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
    Tags Eli Lilly and Co Healthy Returns Health & Science
    From CNBC.com News
    Pfizer moves forward with once-daily version of weight loss pill after setbacks
    Tags Health & Science Companies Breaking News: Business
    From CNBC.com News
    Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
    Tags Novo Nordisk A/S Investing Business
    From CNBC.com News
    FTC to sue drug middlemen over prices of medications including insulin
    Tags Pharmaceuticals Cigna Corp Novo Nordisk A/S
    From CNBC.com News
    CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
    Tickers LAWS
    Tags Streaming services Dow Jones Industrial Average Streaming media technology
    From CNBC.com News
    < Previous 1 2 3 4 5 6 7 8 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.